Pregnancy: There are no data from the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine (Trivasc) during pregnancy.
Breastfeeding: It is unknown whether Trimetazidine/Metabolites are excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine (Trivasc) should not be used during breastfeeding.